Related Experiment Videos
[Immunohistochemical study on HLA expression of human breast cancer]
T Nakazawa1, K Yamamoto, N Kohno
1First Department of Surgery, Kobe University School of Medicine, Japan.
Insights
Most breast cancers show reduced human leukocyte antigen (HLA) class I expression, impacting prognosis. This lack of HLA antigen may hinder immune responses, affecting patient outcomes.
Area of Science:
- Immunology
- Oncology
- Pathology
Context:
- Human leukocyte antigen (HLA) expression is crucial for immune recognition.
- Aberrant HLA expression is observed in various cancers, including breast cancer.
- Understanding HLA expression patterns can provide insights into tumor-immune interactions.
Purpose:
- To investigate the expression levels of HLA class I and class II antigens in breast cancer tissues.
- To correlate HLA expression with histopathological subtypes and patient prognosis in invasive ductal carcinoma.
- To explore the relationship between HLA expression and lymphoid cell infiltration in the tumor microenvironment.
Summary:
- One hundred and nine breast cancer cases were analyzed for HLA expression using immunoperoxidase staining.
- 56% of cases exhibited negative or very weak HLA class I expression, contrasting with normal mammary ductal epithelia.
- HLA expression levels correlated with histopathological subtypes of invasive ductal carcinoma and lymphoid cell infiltration, suggesting a role in immune modulation and prognosis.
Impact:
- Reduced HLA expression in breast cancer may impair the induction of cytotoxic T cells.
- This impairment could modulate the host's immunological response, potentially influencing patient prognosis.
- Findings suggest HLA expression as a potential biomarker for predicting breast cancer outcomes and guiding immunotherapy strategies.
Abstract:
One hundred and nine cases of breast cancer were examined by immunoperoxidase staining of frozen section for their HLA expression. Sixty one cases (56%) were negative or very weak for HLA class I expression, while normal mammary ductal epithelia showed intense positivity in both class I and class II antigens. The extent of expression correlated well with the histopathological subtyping of invasive ductal carcinoma in Japan, which reflects the prognosis quite well. Degree of lymphoid cell infiltration was also proportional to HLA expression by tumor cells. It may be that lack of HLA antigen expression leads to failure of induction of cytotoxic T cells, thus modulating the immunological response and influencing prognosis.